{
    "api_version": "1",
    "drug_rules_version": "0.8",
    "source": "BeatCC",
    "order": {
        "primary_diagnosis": "Neuroblastoma",
        "specimen_site": "Abdominal Mass",
        "specimen_type": "Frozen Tissue",
        "tumor_collection_date": "10/7/2019"
    },
    "biomarkers": [
        {
            "gene": "HDAC2",
            "alteration_type": "overexpression",
            "origin": "RNA",
            "effect": "over, NRZ=9.01, CRC=0.82",
            "drugs": [
                {
                    "drug_name": "VORINOSTAT",
                    "drug_status": "Predicted Beneficial"
                }
            ]
        },
        {
            "gene": "HDAC9",
            "alteration_type": "overexpression",
            "origin": "RNA",
            "effect": "over, NRZ=2.76, CRC=0.79",
            "drugs": [
                {
                    "drug_name": "VORINOSTAT",
                    "drug_status": "Predicted Beneficial"
                }
            ]
        },
        {
            "gene": "CTBP2",
            "alteration_type": "overexpression",
            "origin": "RNA",
            "effect": "over, NRZ=0.74, CRC=0.92",
            "drugs": [
                {
                    "drug_name": "VORINOSTAT",
                    "drug_status": "Predicted Beneficial"
                }
            ]
        },
        {
            "gene": "RET",
            "alteration_type": "overexpression",
            "origin": "RNA",
            "effect": "over, NRZ=2.27, CRC=0.69",
            "drugs": [
                {
                    "drug_name": "SORAFENIB",
                    "drug_status": "Predicted Beneficial"
                }
            ]
        },
        {
            "gene": "TMB",
            "alteration_type": "TMB low",
            "effect": "0.07 mut/Mb"
        },
        {
            "gene": "MSI",
            "alteration_type": "MSI: stable"
        }
    ]
}
